Assessing different rTMS protocols for treating neuropathic pain
Official title: Classical, Spaced, or Accelerated Transcranial Magnetic Stimulation of Motor Cortex for Treating Neuropathic Pain: a 3-arm Parallel Non-inferiority Study
Run by Institut pour la Pratique et l'Innovation en PSYchologie appliquée (Institut Pi-Psy) · NCT06964243 · Data updated 2026-11-12
This study is testing three different types of brain stimulation to see which one helps people with chronic nerve pain feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 36 (estimated) |
| Sponsor | Institut pour la Pratique et l'Innovation en PSYchologie appliquée (Institut Pi-Psy) Academic / other |
| Locations | 1 site (Créteil, Île-de-France Region) |
| Status | Recruiting |
| Started | April 1, 2025 |
| Main results expected | December 19, 2026 |
| Study ends | February 1, 2027 |
| Registry record updated | May 9, 2025 |
| Trial ID | NCT06964243 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 to 80 with chronic peripheral neuropathy and a pain score of 4 or higher on a numerical rating scale.
✕Probably not a fit
Patients with neurological disorders, psychiatric illnesses, or contraindications to TMS will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of three different repetitive transcranial magnetic stimulation (rTMS) protocols in treating patients with chronic peripheral neuropathic pain. A total of 36 patients aged 18 to 80 will be randomly assigned to receive either classical high-frequency rTMS (CHF-rTMS), spaced high-frequency rTMS (SHF-rTMS), or accelerated intermittent theta burst stimulation (ACC-iTBS). The study aims to compare the analgesic efficacy of these protocols to determine the most effective treatment approach for neuropathic pain. Participants will be recruited from the Clinical Neurophysiology department at Henri Mondor University Hospital in France.
Why it matters
Potential benefit: If successful, this study could provide a more effective non-drug treatment option for patients suffering from neuropathic pain.
How similar studies have gone: Previous studies have shown that rTMS can be effective for neuropathic pain, but this specific comparison of protocols is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * (1) existence of a definite peripheral neuropathy on both clinical and neurophysiological grounds, present for at least 6 months; * (2) neuropathic pain clearly related to the neuropathy, as defined by a score ≥ 4/10 on the questionnaire "Douleur Neuropathique en 4 Questions" (DN4) ; * (3) a score ≥ 4/10 on a 0-10 numerical rating scale (NRS) concerning the average intensity of daily ongoing pain; * (4) age between 18 and 80 years; * (5) affiliation with the social security system; * (6) ability to provide signed informed consent. Exclusion Criteria: * (1) concomitant neurological (neurodegenerative disorders, migraine, epilepsy, stroke, tumor) or psychiatric illness; * (2) contraindications related to TMS (intracranial ferromagnetic material); * (3) drug-resistant or active epilepsy.
Where it's running
-
Henri Mondor University Hospital
Créteil, Île-de-France Region, France Recruiting
Study contacts
- Study coordinator: Jean-Pascal Lefaucheur, MD, PhD
- Email: Jean-pascal.lefaucheur@aphp.fr
- Phone: 800-555-5555
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tracking outcomes of intravenous lidocaine for chronic pain
This study tests how well IV lidocaine infusions work for people with chronic pain who are already prescribed the treatment.
-
Cryoneurolysis for Chronic Pain: 6- and 12-Month Outcomes in Routine Care
This study tests whether cryoneurolysis, done as part of standard care for people with chronic pain, leads to meaningful improvements over 6 to 12 months.
-
Therapeutic yoga and interoceptive awareness in adolescents with chronic pain
This will test whether an occupational therapy plan that includes therapeutic yoga helps adolescents (ages 11–21) with chronic pain improve body awareness and day-to-day function.
-
VMD-3866 topical gel for chemotherapy-induced nerve pain
This trial will test whether a non-opioid topical gel called VMD-3866 can reduce pain in adults with chemotherapy-induced peripheral neuropathy.
-
Shiatsu therapy for long-lasting non-inflammatory pain in children and teens
This study will try weekly 30-minute Shiatsu sessions alongside regular care to see if they improve quality of life for children and adolescents (ages 10–18) with non-inflammatory chronic pain.
-
Mind-body approach for treating chronic upper extremity pain
This study is testing a mind-body program to see if it can help people with chronic upper arm and hand pain feel better and improve how well they can use their arms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.